Author:
Borner M M,Brousset P,Pfanner-Meyer B,Bacchi M,Vonlanthen S,Hotz M A,Altermatt H J,Schlaifer D,Reed J C,Betticher D C
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Apolinario, R. M., van der Valk, P., de Jong, J., Deville, W., van Ark-Otte, J. & Dingemans, A. M. (1997). Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol 15: 2456–2466.
2. Betticher, D. C., Heighway, J., Hasleton, P. S., Altermatt, H. J., Ryder, W. D., Cerny, T. & Thatcher, N. (1996). Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 73: 294–300.
3. Boring, C. C., Squires, T. S., Tong, T. & Montgomery, S. (1994). Cancer statistics, 1994. Ca Cancer J Clin 44: 7–26.
4. Borner, C. (1996). Diminished cell proliferation associated with the death-protective activity of Bcl-2. J Biol Chem 271: 12695–12698.
5. Borner, M., Myers, C., Sartor, O., Sei, Y., Toko, T., Trepel, J. & Schneider, E. (1995). Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis and proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res 55: 2122–2128.
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献